Numerous experimental studies suggest that oxidative stress contributes to the pathophysiology of hypertension and importantly, that oxidative stress plays a more definitive role in mediating hypertension in males than in females. Intrauterine growth-restriction induced by reduced uterine perfusion initiated at day 14 of gestation in the rat programs hypertension in adult male growth-restricted offspring; yet, female growth-restricted offspring are normotensive. The mechanisms mediating sex differences in blood pressure in adult growth-restricted offspring are not clear. Thus, this study tested the hypothesis that sex specific differences in renal oxidative stress contribute to the regulation of blood pressure in adult growth-restricted offspring. A significant increase in blood pressure measured by telemetry in male growth-restricted offspring (P<0.05) was associated with a marked increase in renal markers of oxidative stress (P<0.05). Chronic treatment with the antioxidant tempol had no effect on blood pressure in male control offspring, but it normalized blood pressure (P<0.05) and renal markers of oxidative stress (P<0.05) in male growth-restricted relative to male control. Renal markers of oxidative stress were not elevated in female growth-restricted offspring; however, renal activity of the antioxidant catalase was significantly elevated relative to female control (P<0.05). Chronic treatment with tempol did not significantly alter oxidative stress or blood pressure measured by telemetry in female offspring. Thus, these data suggest that sex differences in renal oxidative stress and antioxidant activity are present in adult growth-restricted offspring, and that oxidative stress may play a more important role in modulating blood pressure in male, but not female growth-restricted offspring.
Vaping nicotine (i.e., the use of e-cigarettes and similar devices to inhale nicotine) is becoming increasingly popular among young people. Though some vaporizers are capable of vaporizing cannabis, sparse research has investigated this method of cannabis administration. The present study examines the prevalence and correlates of vaping cannabis in a sample of 482 college students. Participants reported high lifetime rates of vaping nicotine (37%) and cannabis (29%). Men (r = 0.09, p = .047) and individuals from higher socioeconomic status families (r = 0.14, p = .003) vaped cannabis more frequently than women and individuals from lower SES families. In addition, those who vaped cannabis more frequently were more open to new experiences (r = 0.17, p < .001) and showed greater approval of smoking cannabis regularly (r = 0.35, p < .001). Among the largest correlates of cannabis vaping were frequent cannabis use (r = 0.70, p < .001) and nicotine vaping (r = 0.46, p < .001), suggesting that availability of cannabis and vaporizers is particularly important. Participants' top reason for vaping cannabis, endorsed by 65% of those who had vaped cannabis, was convenience and discreetness for use in public places. Several correlates distinguished cannabis users who vaped from cannabis users who did not vape, most notably more frequent cannabis use (odds ratios [OR] = 3.68, p < .001), alcohol use (OR = 2.07, p < .001), nicotine vaping (OR = 1.73, p < .001), and greater approval of smoking cannabis regularly (OR = 2.15, p < .001). Findings suggest that cannabis vaping is prevalent among young adults, particularly among those who use other substances frequently and have more favorable attitudes toward smoking cannabis. Research is needed on the antecedents and potential harms and benefits of cannabis vaping in young adulthood. (PsycINFO Database Record
Background: The coronavirus disease-2019 (COVID-19) pandemic has caused myriad health, social, and economic stressors. To date, however, no known study has examined changes in mental health during the pandemic in the U.S. military veteran population. Methods: Data were analyzed from the 2019-2020 National Health and Resilience in Veterans Study, a nationally representative, prospective cohort survey of 3,078 veterans. Pre-to-peri-pandemic changes in psychiatric symptoms were evaluated, as well as pre-pandemic risk and protective factors and pandemic-related correlates of increased psychiatric distress. Results: The prevalence of generalized anxiety disorder (GAD) positive screens increased from pre-to peri-pandemic (7.1% to 9.4%; p<0.001) and was driven by an increase among veterans aged 45-64 years (8.2% to 13.5%; p<0.001), but the prevalence of major depressive disorder and posttraumatic stress disorder positive screens remained stable. Using a continuous measure of psychiatric distress, an estimated 13.2% of veterans reported a clinically meaningful pre-to-peri-pandemic increase in distress (mean=1.1 standard deviation). Veterans with a larger pre-pandemic social network size and secure attachment style were less likely to experience increased distress, whereas veterans reporting more pre-pandemic loneliness were more likely to experience increased distress.Concerns about pandemic-related social losses, mental health COVID-19 effects, and housing stability during the pandemic were associated with increased distress, over-and-above prepandemic factors. Conclusions: Although most U.S. veterans showed resilience to mental health problems nearly one year into the pandemic, the prevalence of GAD positive screens increased, particularly among middle-aged veterans, and 1-of-7 veterans experienced increased distress.Clinical implications of these findings are discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.